Organisation paid for research Program year 2025 Source: CMS Open Payments

Yazoo Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$281,985

15 payments

Through program year 2025, Yazoo Clinical Research is reported as receiving $281,985 in research payments, across 15 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$437	2
2024	Research	$48,792	3
2023	Research	$68,372	7
2022	Research	$95,818	1
2021	Research	$56,516	1
2020	Research	$12,050	1

Breakdown

Who paid Research payments · program years 2020–2025

Novartis Pharmaceuticals Corporation $281,985 15 payments

Studies the money was for Research payments · program years 2020–2025

Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (Victorion-2 Prevent) $191,020 6 payments
A Randomized Double-Blind, Placebo-Controlled, Multicenter Trial Assessing the Impact of Lipoprotein (A) Lowering With Tqj230 on Major Cardiovascular Events in Patients With Established Cardiovascular Disease $90,486 6 payments
A Multi-Center, Randomized, Double-Blind, Parallel-Group, 20-Week Dose-Finding Study to Evaluate Efficacy, Safety, and Tolerability of Xxb750 in Patients With Resistant Hypertension $479 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.